Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3
Top Cited Papers
Open Access
- 15 May 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 99 (10) , 3806-3812
- https://doi.org/10.1182/blood.v99.10.3806
Abstract
Follicular lymphoma (FL) grades 1 and 2 are regarded as a distinct disease entity, whereas data suggest that FL grade 3 might be an inhomogeneous tumor category. To define the biologic spectrum of FL, 89 follicular lymphomas were studied for their cytologic composition, antigen expression, mitotic and proliferation indices, cytogenetics, and clinical data. In contrast to the homogeneous appearance of FL grades 1 and 2 (29 and 33 cases, respectively), 2 types of FL grade 3 were recognized. Eleven cases of FL 3a displayed structural features similar to those of FL 1 and 2 and were composed of centroblasts and centrocytes, whereas 16 cases of FL 3b, with (n = 4) or without (n = 12) a diffuse large B-cell lymphoma component (DLBL) (FL 3b ± DLBL), consisted exclusively of blasts. In contrast to FL 3a, FL 3b ± DLBL were CD10+ in only 50% of cases and displayed plasmacytoid differentiation in 44% of cases. Although FL3a was t(14;18)+ in 8 of 11 (73%) cases, only 2 of 16 (13%) FL3b ± DLBLs harbored this translocation. In contrast, chromosomal breaks at 3q27 were encountered in 7 of 16 (44%) FL 3b ± DLBL in contrast to only 2 of 11 (18%) FL 3a, and the spectrum of secondary aberrations in FL 3b ± DLBL was similar to that of diffuse large B-cell lymphoma. We conclude, therefore, that FL grade 3 is a heterogeneous disease group and that the distinction proposed in the new World Health Organization classification between FL 3a (with centrocytes) and FL3b (without centrocytes) is of biologic, and possibly clinical, importance.Keywords
This publication has 41 references indexed in Scilit:
- Decreased CD10 Expression in Grade III and in Interfollicular Infiltrates of Follicular LymphomasAmerican Journal of Clinical Pathology, 2001
- Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18)Genes, Chromosomes and Cancer, 2001
- The Hallmarks of CancerCell, 2000
- Analysis of the BCL-6 gene configuration in diffuse B-cell non-Hodgkin's lymphomas and Hodgkin's diseaseThe Journal of Pathology, 1995
- Cytogenetic analysis of 434 consecutively ascertained specimens of non‐Hodgkin's lymphoma: Correlations between recurrent aberrations, histology, and exposure to cytotoxic treatmentGenes, Chromosomes and Cancer, 1991
- Bcl-2 protein expression in follicular lymphomas in absence of 14;18 translocationThe Lancet, 1990
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990
- Correlation of Secondary Cytogenetic Abnormalities With Histologic Appearance in Non-Hodgkin's Lymphomas Bearing t(14;18)(q32;q21)JNCI Journal of the National Cancer Institute, 1988
- Multiple Recurrent Genomic Defects in Follicular LymphomaNew England Journal of Medicine, 1987
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958